Context Therapeutics Inc. (CNTX)Healthcare | Biotechnology | Philadelphia, United States | NasdaqCM
2.43 USD
+0.14
(6.114%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.45 +0.02 (0.823%) ⇧ (April 17, 2026, 7:51 p.m. EDT) Short-term: ★★★★☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:32 p.m. EDT
Context Therapeutics presents a compelling asymmetric risk/reward profile driven by significant FDA catalysts (fast-track status) and substantial cash reserves, though short-term technicals remain volatile amidst recent insider selling signals and a downgraded analyst rating. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.131094 |
| AutoETS | 0.160973 |
| MSTL | 0.162563 |
| AutoARIMA | 0.607573 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 17.74 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.165 |
| Excess Kurtosis | -0.43 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.185 |
| Market Cap | 223,266,400 |
| Forward P/E | -5.25 |
| Beta | 1.83 |
| Website | https://www.contexttherapeutics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.9136691 |
| Address1 | 2,001 Market Street |
| Address2 | Suite 3915 Unit #15 |
| All Time High | 10.87 |
| All Time Low | 0.47 |
| Ask | 2.45 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 776,220 |
| Average Daily Volume3 Month | 1,316,596 |
| Average Volume | 1,316,596 |
| Average Volume10Days | 776,220 |
| Beta | 1.83 |
| Bid | 1.75 |
| Bid Size | 2 |
| Book Value | 0.658 |
| City | Philadelphia |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.43 |
| Current Ratio | 8.523 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.45 |
| Day Low | 2.31 |
| Debt To Equity | 0.185 |
| Earnings Timestamp End | 1,746,648,597 |
| Earnings Timestamp Start | 1,746,648,597 |
| Ebitda | -39,686,380 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.966 |
| Enterprise Value | 157,383,232 |
| Eps Current Year | -0.46556 |
| Eps Forward | -0.4625 |
| Eps Trailing Twelve Months | -0.38 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.6052 |
| Fifty Day Average Change | -0.17519999 |
| Fifty Day Average Change Percent | -0.06725011 |
| Fifty Two Week Change Percent | 191.36691 |
| Fifty Two Week High | 3.62 |
| Fifty Two Week High Change | -1.1899998 |
| Fifty Two Week High Change Percent | -0.32872924 |
| Fifty Two Week Low | 0.49 |
| Fifty Two Week Low Change | 1.94 |
| Fifty Two Week Low Change Percent | 3.9591837 |
| Fifty Two Week Range | 0.49 - 3.62 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,634,736,600,000 |
| Float Shares | 42,716,467 |
| Forward Eps | -0.4625 |
| Forward P E | -5.254054 |
| Free Cashflow | -19,126,216 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 15 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01181 |
| Held Percent Institutions | 0.76802003 |
| Implied Shares Outstanding | 91,879,177 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-20 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania. |
| Long Name | Context Therapeutics Inc. |
| Market | us_market |
| Market Cap | 223,266,400 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_408000800 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -36,123,616 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 225,103,983 |
| Number Of Analyst Opinions | 8 |
| Open | 2.31 |
| Operating Cashflow | -26,385,380 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 267 225 7416 |
| Post Market Change | 0.01999998 |
| Post Market Change Percent | 0.8230445 |
| Post Market Price | 2.45 |
| Post Market Time | 1,776,469,863 |
| Previous Close | 2.29 |
| Price Eps Current Year | -5.219521 |
| Price Hint | 4 |
| Price To Book | 3.6930094 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.229 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.3 |
| Region | US |
| Regular Market Change | 0.14 |
| Regular Market Change Percent | 6.11354 |
| Regular Market Day High | 2.45 |
| Regular Market Day Low | 2.31 |
| Regular Market Day Range | 2.31 - 2.45 |
| Regular Market Open | 2.31 |
| Regular Market Previous Close | 2.29 |
| Regular Market Price | 2.43 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,203,187 |
| Return On Assets | -0.29785 |
| Return On Equity | -0.4639 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 91,879,177 |
| Shares Percent Shares Out | 0.012 |
| Shares Short | 1,105,137 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,152,525 |
| Short Name | Context Therapeutics Inc. |
| Short Percent Of Float | 0.0145000005 |
| Short Ratio | 1.14 |
| Source Interval | 15 |
| State | PA |
| Symbol | CNTX |
| Target High Price | 9.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 6.0 |
| Target Median Price | 5.5 |
| Total Cash | 65,995,228 |
| Total Cash Per Share | 0.718 |
| Total Debt | 112,064 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.38 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.495455 |
| Two Hundred Day Average Change | 0.93454504 |
| Two Hundred Day Average Change Percent | 0.6249235 |
| Type Disp | Equity |
| Volume | 1,203,187 |
| Website | https://www.contexttherapeutics.com |
| Zip | 19,103 |